Charts
8086:ニプロ
Remove from History
Add to History
諸事情によりHistoryの登録はログインユーザーに限定。
Current:
1367.5
PreviousClose:
1378.0
Open:
1384.5
High:
1389.0
Low:
1361.0
Dividend History 31.0
2020-09:
10.5
2021-03:
16.5
2021-09:
14.5
2022-03:
12.5
2022-09:
13.5
2023-03:
8.5
2023-09:
10.0
2024-03:
15.0
2024-09:
12.0
2025-03:
13.0
2025-09:
10.0
2026-03:
19.0
2026-09:
12.0
EPS:
76.76
BPS:
1703.899
ROA:
2.0%
ROE:
5.2%
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filters, hemoconcentrators, and venous and arterial cannulae; and enzymes, as well as contract development and manufacturing services. In addition, the company offers pharmaceutical combination products consisting of dual chamber bags, pre-filled syringes, and half-type kits; and integrated services, such as development, manufacturing, inspection, and packaging. Further, it provides glass containers, rubber stoppers, glass tubes, and other supplies for medical use; supplies for other industries; and drug administration systems, as well as autologous bone-marrow mesenchymal stem cells, culture products, and cell preservation products. The company was founded in 1947 and is headquartered in Settsu, Japan.